Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (the "Company") is dated November 4, 2025. The report primarily addresses the rescheduling of the Company's Annual General Meeting of Shareholders (AGM) and provides an update on a proposed business combination with MBody AI, a Nevada corporation focused on embodied AI-driven automation.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. The document focuses on corporate governance updates and strategic transaction details rather than financial performance metrics.
Material Changes and Transaction Updates
- AGM Rescheduling: The AGM, originally scheduled for October 17, 2025, has been rescheduled to Friday, November 14, 2025, at 10:00 a.m. Eastern Time in Washington, DC.
- Merger Agreement Update: On September 12, 2025, the Company entered into a Merger Agreement with MBody AI. The Board confirms that despite a reported increase in MBody AI's valuation due to strong demand and institutional interest, the originally disclosed exchange ratio will be preserved.
- Reverse Split Proposal: Shareholders will vote on a reverse share split with a ratio ranging from 1-for-2 to 1-for-100. The exact ratio will be determined by the Board. The number of authorized ordinary shares will remain at 18,000,000, and the nominal value will remain at NIS 48.0 per share.
- Name Change: Upon closing, the Company intends to change its name to "MBody AI Ltd." or a similar name approved by the Israeli Registrar of Companies.
Guidance, Outlook, and Risks
Management Commentary and Outlook: Management describes the merger as a strategic alignment to capitalize on the "embodied AI" sector, which they characterize as a "once-in-a-generation category-defining breakthrough." The Company anticipates the combined entity will pursue cross-listing and index incorporation. Management cites market projections suggesting the AI robotics market could reach $16 trillion by 2050.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers. Key risks identified include the failure to satisfy closing conditions, changes in market conditions, regulatory approval delays, integration challenges, and general economic factors. The Company explicitly states it undertakes no obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the exact reverse split ratio to be determined by the Board, as the filing only provides a range (1-for-2 to 1-for-100).
- Confirm the specific terms of the Merger Agreement and the exchange ratio, as referenced in the September 12, 2025 filing.
- Review the attached Proxy Statement (Exhibit 99.2) for detailed voting instructions and director election details.
- Assess the status of closing conditions for the MBody AI merger, as the transaction is contingent upon their satisfaction or waiver.
- Monitor for any updates regarding the Company's financial position, as this filing contains no quantitative financial data.